Legal & General Group’s Acrivon Therapeutics ACRV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
2025
Q1
$1.7K Hold
2024
Q4
$5.08K Hold
2024
Q3
$5.87K Hold
2024
Q2
$4.87K Hold
2024
Q1
$5.93K Hold
2023
Q4
$4.13K Hold
2023
Q3
$8.02K Hold
2023
Q2
$10.9K Sell
2023
Q1
$11.7K Buy